[DISCLOSURE]
HLB (028300) announced on Oct. 15 that it has decided to acquire 1,065,482 shares of its affiliate
HLB Life Science (067630) at 17.5 billion won (US$15.45 million) “to maximize corporate value.”
It will own 3,746,750 shares (10.32 percent stake).
By Hwang You-mee (
glamazon@heraldcorp.com)